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Natural killer (NK) cells have been shown to play a regulatory role in sepsis. According to
the current view, NK cells become activated via macrophages or dendritic cells primed
by lipopolysaccharide (LPS). Recently, TLR4 gene expression was detected in human NK
cells suggesting the possibility of a direct action of LPS on NK cells. In this study, effects
of LPS on NK cell cytokine production and cytotoxicity were studied using highly puriﬁed
human NK cells. LPS was shown to induce IFN-γ production in the presence of IL-2 in NK
cell populations containing >98% CD56+ cells. Surprisingly, in the same experiments LPS
decreased NK cell degranulation. No signiﬁcant expression of markers related to blood
dendritic cells, monocytes orT or B lymphocytes in the NK cell preparations was observed;
the portions of HLA-DRbright, CD14+, CD3+, and CD20+ cells amounted to less than 0.1%
within the cell populations. No more than 0.2% of NK cells were shown to be slightly
positive for surface TLR4 in our experimental system, although intracellular staining
revealed moderate amounts of TLR4 inside the NK cell population. These cells were
negative for surface CD14, the receptor participating in LPS recognition byTLR4. Incubation
of NK cells with IL-2 or/and LPS did not lead to an increase in TLR4 surface expression.
TLR4−CD56+ NK cells isolated by cell sorting secreted IFN-γ in response to LPS. Antibody
to TLR4 did not block the LPS-induced increase in IFN-γ production. We have also shown
that Re-form of LPS lacking outer core oligosaccharide and O-antigen induces less cytokine
production in NK cells than full-length LPS.We speculate that the polysaccharide fragments
of LPS molecule may take part in LPS-induced IFN-γ production by NK cells. Collectively
our data suggest the existence of a mechanism of LPS direct action on NK cells distinct
from establishedTLR4-mediated signaling.
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INTRODUCTION
Natural killer (NK) cells are the major interferon-gamma (IFN-γ)
producers in the early stages of the immune response (Artavanis-
Tsakonas and Riley, 2002; Thäle and Kiderlen, 2005). IFN-γ
production can be triggered in NK cells as a result of contact
and recognition of target cells after activating interactions with
other immune cells, particularly with dendritic cells (DC) and
macrophages, or under the action of various cytokines, notably
IL-12, IL-18, and IL-2, produced at different stages of infection
and inﬂammation (Gerosa et al., 2002; Cooper et al., 2004; Tu
et al., 2008).
Natural killer cells possess multiple sensors on their surface
for the detection of PAMP (pathogen-associated molecular pat-
terns) and DAMP (damage-associated molecular patterns) caused
by infection or cell stress (Chalifour et al., 2004). A number of
studies in vitro and in vivo have shown that NK cells can be acti-
vated by lipopolysaccharide (LPS), the component of the outer
membrane of Gram-negative bacteria (Goodier and Londei, 2000;
Varma et al., 2002). NK cells now seem to be one of the impor-
tant cell types participating in the septic inﬂammatory process
(reviewed in Chiche et al., 2011; Souza-Fonseca-Guimaraes et al.,
2012a). Several studies have demonstrated that LPS can activate
NK cells indirectly. LPS primarily activates DC or macrophages
through the established LPS receptor TLR4 (Toll-like receptor 4)
triggering production of cytokines (IL-12, IL-18) and surface
expression of several stimulating ligands in these cells, includ-
ing B-7 and some NKG2D ligands, leading to NK cell activation
(Goodier and Londei, 2000; Gerosa et al., 2002). This model of
indirect NK cell activation by LPS is now generally accepted. Alter-
natively, it has been proposed that LPS directly inﬂuences NK
cells by engaging TLR4 on the NK cell surface. Several reports
suggest that human NK cells express TLRs, particularly, TLR2
and TLR4, at least on the mRNA level (Saikh et al., 2003; Lau-
zon et al., 2006; Mian et al., 2010; Chiche et al., 2011). Recently
intracellular TLR4 expression was shown for NK cells (Souza-
Fonseca-Guimaraes et al., 2012b). Direct activating effects of the
agonists of TLR2, 3, 7, 8, and 9 on NK cell activity have been
demonstrated (Becker et al., 2003; Sivori et al., 2004; Gorski et al.,
2006; Lauzon et al., 2006; Sawaki et al., 2007; Toka et al., 2009).
Both surface expression (O’Connor et al., 2005) and functional
activity (Mian et al., 2010) of TLR4 have also been detected in
human NK cells. Collectively, these data favor the hypothesis of
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both direct and indirect mechanisms for LPS modulation of NK
cell activity.
In this study, we investigated the hypothesis of direct action of
LPS on NK cells. A stimulating effect of LPS on cytokine-induced
IFN-γ production was observed in highly puriﬁed fractions of
human NK cells isolated by magnetic separation. Increase of IFN-
γ production in these experiments corresponded to a decrease in
NK cell degranulation in response to K562 target cells. Surpris-
ingly we did not detect any signiﬁcant surface TLR4 expression in
the cells that produced increased amount of IFN-γ. Instead, we
demonstrated that these cells were slightly positive for intracel-
lular TLR4. Using ﬂow cytometry multicolor analysis we found
only negligible numbers of DC, monocytes, T and B cells within
the isolated CD56+ cell population. Moreover, NK cells isolated
by ﬂuorescence-activated cell sorting (FACS) with intentional
exclusion of surface TLR4-positive cells responded well to LPS
stimulation. Blocking antibody to TLR4 did not inhibit the
LPS-induced increase of IFN-γ production suggesting the exis-
tence of a mechanism of LPS activation distinct from established
TLR4-mediated signaling.
MATERIALS AND METHODS
ISOLATION OF HUMAN NK CELLS AND CULTURE CONDITIONS
Adult volunteers gave informed consent for their blood to be
used in this study, which was approved by ethics committees of
The Russian State Medical University. Peripheral blood mononu-
clear cells (PBMC) were isolated from heparinized whole blood
by centrifugation on Ficoll gradients with a density of 1.077 g/ml
(ICN). Two strategies were used to purify NK cells. First, magnetic
separation of NK cells was performed using a NK cell nega-
tive isolation kit (Miltenyi Biotec, Bergisch Gladbach, Germany)
according to the manufacturer’s protocol using LD columns. The
percentage of CD56+ cells in the preparations after separation
was routinely 95–99% as veriﬁed by ﬂow cytometry. Second,
CD3−CD14−CD56+TLR4− cells were separated from PBMC
fraction by ﬂuorescent-activated cell sorting. The post-sort pop-
ulation purity was always greater than 95%. Isolated NK cells
were cultivated in 96 U-well plates (Costar) in an incubator set
at 5% CO2 and 37◦C at cell concentrations of 1.5 × 106 cells/ml
in culture medium consisted of RPMI-1640 supplemented with
10% heat-inactivated FCS (HyClone), 2 mM L-glutamine and
antibiotic-antimycotic solution (1:100; Sigma-Aldrich, St. Louis,
MO, USA) for 18 h. Recombinant human IL-2 purchased from
Hoffmann-La-Roche (500U/ml), recombinant human IL-12 from
Sigma-Aldrich (10 ng/ml), LPS from E. coli strain 026:B6 (Sigma-
Aldrich) or Kdo2-lipid A from E. coli K15 heptose-deﬁcient strain
WBB06 (ENZO Life Sciences) were added to the cell culture. Prior
to use the vials containing LPS and lipid A preparations were
shaken by vortex mixer for 30 s and sonicated.
SURFACE FLUORESCENT IMMUNOSTAINING, FLOW CYTOMETRY, AND
CELL SORTING
Cell labelingwith ﬂuorochrome-conjugated antibodies and subse-
quent ﬂow cytometry analysis was used to determine the presence
and percentage of leukocyte subsets and to characterize antigen
surface expression in isolated NK cells. The following conju-
gated anti-human antibodies were: CD3-FITC (BioLegend, San
Diego, CA, USA), CD3-PE-Cy7 (Beckman Coulter, Brea, CA,
USA), CD3-PE (Invitrogen Life Technologies, Carlsbad, CA,
USA),CD56-APC (BeckmanCoulter), CD56-PE (Dako,Glostrup,
Denmark), CD14-PE (BD Pharmingen, San Diego, CA, USA),
CD20-PerCP (BD Pharmingen), anti-TLR4 and anti-TLR4-FITC
(clone HTA125, HyCult Biotech), anti-TLR4 (clone HT52, eBio-
science), CD11c-PE-Cy5 (BioLegend), CD141-PE (BioLegend),
CD303-APC (Miltenyi Biotec), HLA-DR-FITC (BD Pharmingen),
HLA-DR-PE (eBioscience), isotype control IgG2a (eBioscience).
Cells were incubated with a premixed antibody cocktail in PBS
containing 0.5% BSA and 0.1% sodium azide for 30 min on
ice, washed twice and subsequently analyzed by ﬂow cytome-
try. Samples were analyzed on a FACSCalibur ﬂow cytometer
(BD Biosciences, San Jose, CA, USA), equipped with 488 and
640 nm lasers. Multicolor sample analysis and cell sorting were
performed on a FACSVantage DiVa cell sorter (BD Biosciences)
equipped with 405, 488, and 643 nm lasers and an appropriate set
of detectors and ﬁlters. Compensation was calculated using the
automated compensation algorithm in the DiVa acquisition soft-
ware. For accurate analysis of rare cell populations no less than
400000 lymphocyte gated events per sample were acquired and
analyzed. Cell sorting was carried out at a sheath pressure of 27 psi
using a 70-μm nozzle. Cell purities following cell sorting always
exceeded 95%.
TLR4 INTRACELLULAR STAINING
Intracellular staining was performed using a CytoFix-CytoPerm
Kit (BD Biosciences) according to manufacturer’s instruction. NK
cells were ﬁxed and permeabilized, then labeled with anti-TLR4-
FITC (clone HTA125) or isotype control antibody.
IFN-γ PRODUCTION MEASUREMENT
Cell-free supernatants were collected fromunstimulated and stim-
ulated (IL-2, IL-12, or LPS)NK cells after 18 h incubation. Samples
were analyzed using an IFN-γ ELISA kit (Vector-Best, Russia)
according to the manufacturer’s instruction. Brieﬂy, supernatants
were transferred into plate wells coated with immobilized anti-
body to IFN-γ and incubated for 2 h. After washing (ﬁve times)
biotinylated antibody to IFN-γ was added for 1 h. After an addi-
tional wash streptavidin conjugated with horseradish peroxidase
(HRP) was added for 30 min. The chromogenic HRP substrate
TMB was added and after 25 min the reaction was terminated
with 1 M sulfuric acid. Plates were read using a Multiscan FC
plate reader (Thermo Fisher Scientiﬁc) set to 450 nm absorption
wavelength with reference wavelength of 620 nm.
ANTIBODY BLOCKING ASSAY
Antibodies to human TLR4 (clone HTA125, BioLegend, and clone
HT52, eBioscience) with established blocking activity were used
for TLR4 neutralization. NK cells isolated by magnetic separa-
tion were preincubated with anti-TLR4 antibody (5 μg/ml) for
40 min at 37◦C prior to LPS stimulation. IFN-γ concentrations in
supernatants were analyzed by ELISA.
DEGRANULATION ASSAY
Natural killer cell cytolytic potential was assessed with a degranu-
lation assay based on LAMP-1 (CD107a) cell surface mobilization
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following NK cell incubation with MHC class I-negative K562
target cells (Alter et al., 2004). In this test, NK cells stimulated
for 18 h with IL-2 alone or with IL-2 and LPS (5 μg/ml) were
mixed with K562 cells in ratio 1.5:1, centrifuged shortly to start
cell-to-cell contact and incubated for 3 h in the presence of
PE-Cy5-conjugated anti-human CD107a antibody (eBioscience)
and monensin (5 μg/ml, Sigma-Aldrich). Samples without tar-
get cells were included to control for spontaneous degranulation.
Cells were then washed with PBS containing 0.5% BSA and 0.1%
sodium azide and stained with CD3-FITC and CD56-PE antibod-
ies as described above. CD3−CD56+ cells were then analyzed by
ﬂow cytometry, and percentages of CD107a-positive cells were
calculated.
DATA ANALYSIS AND STATISTICS
Experimental data statistical analysis of results was performed
using the Student’s unpaired t-test. Values of P < 0.05 were con-
sidered statistically signiﬁcant. All of the error bars in the graphs
represent standard deviations. Flow cytometry data were analyzed
using WinMDI version 2.8 (Joe Trotter, Scripps Institute) and
FlowJo ver. 7.6 (TreeStar, Ashland, OR, USA) software.
RESULTS
LPS INDUCES IFN-γ PRODUCTION IN NK CELLS STIMULATED WITH IL-2
We evaluated cytokine production in response to LPS in NK cell
populations puriﬁed by magnetic separation based on the strat-
egy of lineage-negative NK cell selection. The amount of residual
non-NK cells in the population was then measured. Only cell
preparations with a high content of CD56+ cells (>96%) were
used in these experiments. Isolated NK cells were stimulated for
18 h with cytokines (IL-2 or IL-12) and with LPS. IFN-γ con-
tents in culture supernatants were then analyzed by ELISA. It was
found that LPS, added to NK cells alone, did not signiﬁcantly
affect IFN-γ production (Figure 1A). Addition of LPS simultane-
ously with IL-2 led to an increase in IFN-γ level. Co-stimulating
effects of LPS on IFN-γ production were not restricted to IL-2-
induced activation of NK cells. A LPS-mediated increase of IFN-γ
production was also found in cultures of NK cells treated with
IL-12 indicating that both IL-2 and IL-12 may play accessory role
for the LPS action manifestation (Figure 1A). Combinations of
IL-2 and IL-12 were used as a positive control; IFN-γ level in
these samples always exceeded IFN-γ levels in cultures of NK
cells stimulated with IL-2 or IL-12 alone. The minimal dose of
LPS inducing the IFN-γ elevation in NK cells was 0.5 μg/ml;
doses of LPS from 0.5 to 4 μg/ml were found to have percepti-
ble effects on IFN-γ production (Figure 1B). Lower doses did not
signiﬁcantly inﬂuence the NK cell function. The highest purity
of CD56+ cells registered in cell preparations responding to LPS
by the elevation of IFN-γ production was 99%. It is important
to note that the stimulating effect of LPS was not observed in
some NK cell preparations. Out of 18 blood samples from healthy
donors analyzed, 3 of them did not respond to LPS, 3 samples
showed considerable inhibitory effects, and 12 samples demon-
strated signiﬁcant increase of IFN-γ production. There were great
inter-individual differences in IFN-γproduction; but no clear rela-
tionship was observed between initial IFN-γ levels and responses
to LPS.
CHARACTERIZATION OF ISOLATED NK CELL PREPARATIONS
A critical factor of our experiments was the purity of isolated NK
cell populations with minimal contamination by other cells types.
This was particularly important to exclude cells expressing TLR4,
a potential receptor for LPS. Detailed ﬂow cytometric analysis of
cell fractions was routinely performed after each NK cell magnetic
separation (Figure 2). As a rule these cell preparations contained
minimal amounts of CD3+, CD14+, and CD20+ cells, with the
percentages for these subsets not exceeding 0.1% (Figure 2A).
Analysis of TLR4 expression was performed to identify in the
NK cell preparations the cell types responding to LPS stimula-
tion. An example of a typical cell preparation analysis is presented
in Figure 2B. In the data forward and side scatter plot three
regions can be distinguished: R1 – the usual lymphocyte region;
R2 – the usual monocyte region; and R3 – the usual granulocyte
region. R1 region consisted almost entirely of CD56+ NK cells
(97–99%). Virtually no cells in this region expressed detectable
TLR4. CD56− cells in this region were all TLR4-negative. In some
cases we detected a very small population (not more than 0.2%)
of CD56+TLR4+ cells in this region. CD56bright cells were usu-
ally TLR4-negative. The majority of cells in R2 region was CD56+
and represented doublets. Granulocytes (R3 region) composed
0.05–2% of all registered events in different samples; they usu-
ally did not exceed 0.5%. Most of the cells in R3 region were
CD56-negative and were also negative for TLR4. Importantly, the
stimulating effects of LPS did not depend on the amount of cells in
the sample detected in the granulocyte region. Together, these data
showed that there were no cell populations with high expression
of TLR4 receptor in the isolated NK cell preparations. It should be
noted that after incubation of NK cells with IL-2 and/or LPS the
TLR4 surface expression level did not substantially change (data
not shown).
Recently, CD56 weakly-positive populations have been identi-
ﬁed among myeloid DCs (Milush et al., 2009). We discriminated
DCs in the isolated NK cell preparations using HLA-DR expres-
sion. In a few preparations we had detected HLA-DRbright cell
population indicating contamination of the samples by DCs
(Figure 3). Expression of the plasmacytoid and myeloid blood
DC subpopulation markers CD303, CD141, CD1c was also ana-
lyzed by ﬂow cytometry. As a rule these cells were not detected in
the NK cell preparations (data not shown). NK cells stimulated by
IL-2 were stained intracellularly with anti-TLR4 antibody. It was
shown that although NK cells were not positive for surface TLR4,
they expressed intracellular TLR4 (Figure 2C).
EFFECTS OF LPS ON IFN-γ PRODUCTION OF NK CELLS ISOLATED BY
CELL SORTING
To determine the role of TLR4 in LPS-induced IFN-γ secretion by
NK cells, we performed FACS of CD56+ NK cells not expressing
TLR4. Blood samples for this series of experiments were collected
from donors whose NK cells responded to LPS by increase of
IFN-γ production. PBMC isolated by centrifugation using Ficoll
gradients were stained with antibodies to CD3, CD14, CD56, and
TLR4. CD3−CD14−CD56+TLR4− cells were then separated by
FACS (Figure 4). Subsequent ﬂow cytometric analysis of sorted
cell fractions showed that sorted cells were all TLR4-negative. It
is important to note that these cell populations were negative for
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FIGURE 1 | Co-stimulating influence of LPS on NK cell IFN-γ
secretion. Human NK cells were stimulated for 18 h with cytokines
and LPS. Supernatants were harvested and analyzed for IFN-γ by
ELISA. Data are mean ± SD of triplicate wells in one representative
individual experiment. *P < 0.05, ***P < 0.001, comparisons were
shown between cells, stimulated by a cytokine with LPS, and cells,
stimulated by the cytokine alone. (A) NK cells were incubated in the
presence or absence of IL-2 (500 U/ml) or IL-12 (10 ng/ml) and LPS
(5 μg/ml). Combination of IL-2 and IL-12 was used as a positive control.
(B) NK cells were stimulated with IL-2 (500 U/ml) and different doses
of LPS. Results of one experiment are shown from the group of
experiments demonstrating an increase of IFN-γ secretion under LPS
action (12 different donors). Other experiments showed similar effects
but differed in IFN-γ level.
CD14, a known co-receptor for TLR4. Cells collected after sorting
were resuspended in culture medium and stimulated with 500
U/ml IL-2 and 1 μg/ml LPS as described above. The magnitude of
the LPS effects differed again between donors. At the same time
the samples of sorted NK cells demonstrated higher level of IFN-
γ production in response to LPS stimulation in comparison with
magnetically separated NK cells. This difference may be connected
with additional activation of antibody-labeled NK cells during the
sorting procedure. These results demonstrated that LPS caused
enhanced IFN-γ production by NK cells independently of surface
TLR4 and CD14 expression.
EFFECTS OF LPS ON NK CELL CYTOTOXICITY
Cytotoxic activity of NK cells stimulated by LPS and IL-2 was
estimated in a number of NK cell preparations using a LAMP-
1 release assay. Surprisingly, in cell samples where LPS caused an
increase of IFN-γ production, LPS treatment resulted in a decrease
of K562-dependent NK cell degranulation (Table 1).
BLOCKING ANTIBODIES TO TLR4 DO NOT INHIBIT LPS-INDUCED IFN-γ
PRODUCTION IN NK CELLS
Another approach to investigation of the role of TLR4 in LPS-
induced IFN-γ production by natural killer cells is to block
the TLR4 receptor with a speciﬁc blocking antibody. In these
experiments we used an anti-human TLR4 antibody with estab-
lished blocking activity (clone HTA125; Wang et al., 2001, 2003).
Anti-TLR4 antibody was added to freshly isolated (by magnetic
separation) NK cells in culture medium. Cells were incubated for
40 min with IL-2 (500 U/ml) and LPS in different doses (from 0.5
to 4.0 μg/ml) without washing of NK cells from antibody. Incu-
bation conditions were the same as described above. According to
the literature (Wang et al., 2001, 2003) an antibody concentration
of 5 μg/ml should lead to at least half-inhibition of LPS-induced
cytokine production. However, addition of the antibody did not
change IFN-γ level at any LPS dose (Figure 5). Higher concentra-
tions of antibody (20 and 50μg/ml)were checked in similar exper-
iment conditions. This treatment led to a non-speciﬁc decrease in
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FIGURE 2 | Cytometric analysis of NK cell population purity and
expression ofTLR4. (A) Freshly isolated NK cells were stained with
ﬂuorochrome-labeled antibodies CD3-FITC, CD14-PE, CD20-PerCP, and
CD56-APC and analyzed by ﬂow cytometry. (B) Here is shown one of typical
results from 18 blood samples used in these experiments. Expression of
TLR4 was measured using anti-TLR4-FITC antibody (clone HTA125). Forward
scatter (FS) versus side scatter (SS) is presented. Three regions of live cells
can be distinguished based on morphology. R1 region (95.15% of all events)
consists of CD3−CD56+ NK cells (98.6%). CD56− cells do not expressTLR4.
A small population of CD56+TLR4dim cells (∼0.1%) is detected. On the
histogramTLR4 level and isotypic control are shown. R2 region (0.4%)
consists of NK cells doublets. R3 region (0.48%) corresponds to granulocytes.
(C) Intracellular TLR4 expression in NK cells. Black line – autoﬂuorescence
control, green – isotype control, red – ﬁxed cells, labeled with anti-TLR4-FITC.
IFN-γ production in all samples (data not shown). These experi-
ments were repeated using another inhibitory anti-TLR4 antibody
(clone HT52; Tsukamoto et al., 2012), again with no inhibition of
the LPS effect (data not shown). Thus, blocking antibodies to
TLR4 did not inhibit LPS-induced IFN-γ production in NK cell
preparations.
COMPARISON OF THE EFFECTS OF LPS AND LIPID A ON IFN-γ
PRODUCTION BY NK CELLS
It is known that LPS interacts with TLR4 via the lipid A part of
the LPS molecule. Mutant forms of LPS lacking O-antigen or both
O-antigen and the core oligosaccharide residues but with an intact
lipid A region have been shown to intensively induce cytokine
production in immune cells through the same signaling pathway
as the full-length LPS molecule (Ha et al., 1985; Tamai et al., 2003).
To analyze the role of the lipid A fragment in the LPS effects
on NK cell activity, we compared the S-form of LPS (whole LPS
molecule) and the Re-form (lipidA) onNK cell IFN-γ production.
The molecular mass of the Re-form of LPS is approximately four
times less than the whole LPS molecule and therefore the same
concentration of Re-LPS contains four times more of endotoxin
molecules. It is therefore possible that the relativemagnitude of the
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FIGURE 3 | Expression of HLA-DR was analyzed in different cell samples.
Freshly isolated NK cells were stained with ﬂuorochrome-labeled antibodies
CD56-APC and HLA-DR-FITC and analyzed by ﬂow cytometry. Donor A: one
of typical NK cell preparations with very small amount of HLA-DRbright blood
DC cells. Donor B: NK cell preparation containing a fraction of HLA-DRbright
blood DC cells.
FIGURE 4 | NK cells were stained with fluorochrome labeled antibodies
and sorted using FACSVantage machine. (A) Sort scheme is presented.
Gate for lymphocytes was used, then cells were negatively gated for CD3
and CD14, thanTLR4-negative CD56+ cells were chosen for sorting. (B)
Post-sort purity of CD56+ cells was no less than 95%, noTLR4-positive cells
were detected. (C) Histograms represent three independent experiments
with NK cells from three donors. NK were isolated by cell sorting, than
stimulated with IL-2 (500 U/ml) and LPS (1 μg/ml) in duplicate wells.
Supernatants were harvested and analyzed for IFN-γ by ELISA. Data are
mean ± SD, *P < 0.05, ***P < 0.001.
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Table 1 | Divergent effects of LPS on NK cell cytokine production and cytotoxicity.
IFN-γ production (pg/ml) Degranulation (% CD107a+ cells)
IL-2 IL-2 + LPS P -value IL-2 IL-2 + LPS P -value
Exp. 1 59.0 ± 5.7 130 ± 24 0.027 20.2 ± 0.4 14.2 ± 1.6 0.008
Exp. 2 2.0 ± 3.5 8.8 ± 0.9 0.040 30.9 ± 1.7 21.1 ± 0.5 0.016
Exp. 3 0 398 ± 343 0.028 45.3 ± 0.9 27.6 ± 3.5 <0.001
Natural killer cells were stimulated by IL-2 (500 U) alone or by combined treatment with IL-2 and LPS (5 μg/ml) for 18 h. Cytolytic activity of NK cells was estimated
by LAMP-1 degranulation assay. IFN-γ levels in supernatants were measured by ELISA. Data are mean ± SD of triplicate wells in individual experiments.
FIGURE 5 | NK cells isolated by magnetic separation were
preincubated with anti-TLR4 antibody (clone HTA125; 5 μg/ml) for
40 min 37◦C, than stimulated by IL-2 (500 U/ml) and different doses of
LPS. Supernatants were harvested and analyzed for IFN-γ by ELISA. Data
are mean ± SD from one of three experiments with similar results.
response of NK cells to Re-form would be higher than full length
LPS molecule based on concentration alone. But in most cases
the effect of lipid A was undetectable or insigniﬁcant (Figure 6A).
However in a few experiments we found stimulating effects of
Re-form at the same dose as S-form (5 μg/ml) (data not shown).
In contrast, when we analyzed the effect of these LPS forms on
IFN-γ production in NK cell preparation containing blood DC
cells highly positive for HLA-DR (Figure 3B), the Re-form had
a stimulating effect at doses as small as 10 ng/ml (Figure 6B) in
accordance with published data (Gerosa et al., 2002). These results
suggest that the lipid A fragment is less important for direct action
of LPS on NK cells, and that the polysaccharide portion of the LPS
molecule takes part in NK cell activation.
We can therefore summarize, that: (1) NK cells expressed very
low levels of TLR4 (or did not express it at all); (2) puriﬁed NK
cells, with minimal non-NK cells presence, responded to LPS by
increasing IFN-γ production; (3) sorted CD14−TLR4− NK cells
responded well to LPS stimulation; (4) blocking antibody to TLR4
did not inhibit LPS-induced IFN-γ production; and (5) there were
differences between effects of S-form and Re-form of LPS on NK
cell activity.
DISCUSSION
Previous studies have shown that NK cells take part in the sys-
temic inﬂammatory process during of sepsis (Varma et al., 2002;
Chiche et al., 2011; Souza-Fonseca-Guimaraes et al., 2012a). LPS-
stimulatedDCs andmacrophages activateNKcells using cytokines
and contact interactions. On the other hand, IFN-γ produced by
NK cells is a potent activator of DCs and macrophages. Thus,
NK cells are among the major multipliers of systemic inﬂamma-
tory response in sepsis. However, additional investigations of LPS
inﬂuence onNKcell activity are necessary for better understanding
of the role of these cells in sepsis pathogenesis. Here we demon-
strate that LPS can directly stimulate IFN-γ production in human
NK cells. This effect appears to be independent of TLR4, a known
receptor for LPS.
First of all, we have found that highly puriﬁed NK cells isolated
by magnetic separation from human peripheral blood of healthy
volunteers respond to LPS in the presence of activating cytokines
IL-2 and IL-12 (Figure 1). Signiﬁcant co-stimulating effects of
LPS on IFN-γ production were detected at doses of 0.5–5 μg/ml.
However, one-third of samples did not respond to LPS by ele-
vation of IFN-γ production. LPS effects on NK cells have been
recently reported in a few publications. LPS was shown to have a
weak stimulating effect on IFN-γ production in puriﬁed human
NK cells (Lauzon et al., 2006; Mian et al., 2010). It should be noted
that there are signiﬁcant difference in experimental conditions
between the previous works and the present study. The previous
studies used lower concentration of IL-2 (50 U/ml), longer time of
incubation (48h), lower doses of LPS (100ng/ml) anddifferent cell
concentrations (2×106/ml).Wedidnot detect any effect of LPSon
NK cells without orwith lowdoses of IL-2 (100U/ml). The present
study nevertheless demonstrated that the optimal conditions for
LPS-induced IFN-γ production by NK cells can be found. The
co-stimulating effect of LPS on cytokine-activated NK cells was in
fact reported in another recent work (Souza-Fonseca-Guimaraes
et al., 2012b). Authors compared the inﬂuence of LPS on NK cells
in healthy donors and patients with sepsis and systemic inﬂam-
matory response syndrome. In contrast to the healthy donors, NK
cells of the patients did not display an increase in IFN-γ produc-
tion in response to LPS. We speculate that LPS unresponsiveness
of some donors observed in our study cohort may be explained
by changes in the functional status of NK cells due to some
unknown inﬂammation-related conditions in the donor medical
history.
The purity of NK cells used in these previous studies may not
be sufﬁcient to clearly demonstrate that LPS acts directly on NK
cells. One group of authors reported 3–5% of CD56− cells in their
NK cell preparations (Lauzon et al., 2006), while whole blood sam-
ples were used in another study (Souza-Fonseca-Guimaraes et al.,
2012b). In ourworkwehave performed careful cytometric analysis
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FIGURE 6 | Comparison of effects of S- and Re-forms of LPS on
IFN-γ production by NK cells. (A) Re-form of LPS (lipid A) does not
alter signiﬁcantly IFN-γ production in NK cells at the same concentration
as the S-form (full-length LPS; 5 μg/ml). Data from one of four experiments
with similar results are presented. (B) Signiﬁcant increase of IFN-γ
secretion is induced by low dose of lipid A (10 ng/ml) in NK cell
preparation containing a fraction of HLA-DRbright blood DCs (donor B,
Figure 3).
of isolated NK cell populations, demonstrating the exclusion of
contaminating cell types (Figure 2). The elevation of IFN-γ pro-
duction in response to LPS has been demonstrated in the sample
containing 99% of CD56+ cells.
A critical factor in the present investigation was the num-
ber of TLR4-positive cells within the isolated cell preparations.
We found virtually no TLR4 expression in non-NK cells. This
strongly suggests that LPS can act only through NK cells in
our studies. However, analysis of TLR4 expression on NK cells
has shown that these cells are also mostly negative for TLR4
as well. Only very small populations of TLR4dim NK cells were
detected in a few experiments. This is in contrast to a previous
study, which reported that CD56dim NK cells were all TLR4-
positive (O’Connor et al., 2005). Nevertheless, in another study
(Tadema et al., 2011), only about 0.3–0.5%humanNKcells express
TLR4, in good agreement with our data. Importantly, stimula-
tion of NK cells with IL-2 and/or LPS did not lead to signiﬁcant
increase of TLR4 expression. In the present study, LPS therefore
appears to act on cells displaying no surface TLR4 or expressing
considerably lower levels of the receptor comparing with mono-
cytes or neutrophils. Further evidence for the independence of
LPS action on surface TLR4 was our demonstration that sorted
CD3−CD14−CD56+TLR4− cells respond well to LPS (Figure 4).
Finally, experiments with blocking antibody to TLR4 also showed
that TLR4did not seem tomediate the LPS induced IFN-γ produc-
tion by NK cells. However, intracellular staining with anti-TLR4
antibody revealed considerable amounts of TLR4 inside NK cells
(Figure 2C). Intracellular expression of TLR4 in NK cells has
been recently reported (Souza-Fonseca-Guimaraes et al., 2012b).
However, increased TLR4 expression in NK cells in patients with
sepsis was accompanied by a reduced IFN-γ response to LPS. The
phenomenon of intracellular TLR4 expression in NK cells does
not fully exclude the possibility of TLR4 participation in NK cell
response to LPS. Previous studies have proposed a role for TLR4
trafﬁc between the Golgi apparatus and the plasma membrane
(Latz et al., 2002;Husebye et al., 2006). The authors reported apool
of TLR4 molecules in the Golgi and suggested the participation of
the intracellular TLR4 in LPS signaling. Additionally, intracellular
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interaction of LPS with TLR4 in the Golgi was detected in intesti-
nal epithelial cells (Hornef et al., 2003). A recent study also
demonstrated that LPS can be recognized by intracellular TLR4
in macrophages (Shibata et al., 2011). These ﬁndings suggest that
LPS can use an alternative, intracellular pathway. However, exper-
imental evidence for this hypothesis remains limited. According
to our data, the Re-form of LPS acts on NK cells by a different
mechanism than the full-length LPS molecule. This may indi-
cate that the LPS effects are less dependent on lipid A fragment
and may be mediated at least in part by polysaccharide fragment
of LPS.
In our study, LPS treatment resulted in a remarkable decrease
of NK cell degranulation in response to K562 target cells, inversely
proportional to IFN-γproduction. Thedivergenceof NKcell func-
tional activities distinguishes the mechanism of direct LPS action
on NK cells from the well-known mechanism of indirect effects
of LPS via secretion of multiple cytokines in antigen-presenting
cell populations of the innate immune system (Gerosa et al., 2002;
Cooper et al., 2004; Tu et al., 2008). Previously the differences in
pathways leading to cytokine production and cytotoxicity have
been described for several signaling molecules (Hesslein et al.,
2006; Rajagopalan et al., 2006). It is also possible that under
different conditions the same molecules can perform different
functions. LPS may provide differential regulation of NK cell
activity depending on the microenvironment.
It is also possible that LPS interacts with receptors on the NK
cell surface other than TLR4. Recently, CD6, the scavenger recep-
tor of the cysteine-rich superfamily, has been shown to bind LPS
resulting in activation of the MAPK signaling cascade (Sarrias
et al., 2007). CD6 surface expression has also been detected on of
CD56dim NK cell subpopulation (Braun et al., 2011). Stimulation
of the CD6 receptor by speciﬁc antibody cross-linking leads to
cytokine secretion but not to cell degranulation. Interestingly, IL-
2 was shown to play a co-stimulatory role in the CD6-mediated
signaling.
In summary, we have found that LPS can stimulate IFN-γ pro-
duction in NK cells, but the mechanism of its action remains
unclear. Surface TLR4, a known LPS receptor, seems to play no
role in this process.
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